Search research articles
Contact Us
Filters
Showing results (271-280 of 400) with videos related to
Page
of 40
Sort By:
Cancer Research
|
June 15, 1989
Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)
B A Conley, A Forrest, M J Egorin, et al.
Journal of Clinical Pharmacology
|
August 1, 1995
Effect of aging on atenolol pharmacokinetics and pharmacodynamics
K M Sowinski, A Forrest, J H Wilton, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1995
Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants
M A Amantea, R A Bowden, A Forrest, et al.
Human Reproduction Update
|
February 24, 2001
Efficacy of nafarelin in assisted reproductive technology: a meta-analysis
J M Wong, K A Forrest, S Z Snabes, et al.
Cancer Research
|
June 1, 1989
A limited sampling strategy for cyclophosphamide pharmacokinetics
M J Egorin, A Forrest, C P Belani, et al.
Journal of Hepatology
|
March 26, 1998
Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis
G L Bird, A T Prach, A D McMahon, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1987
Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients
G L Drusano, K I Plaisance, A Forrest, et al.
Scottish Medical Journal
|
January 1, 1976
Effect of histamine H2-receptor blockade on gastric emptying and serum gastrin in man
J A Forrest, R C Heading, J Park, et al.
Cancer Research
|
January 1, 1992
Use of adaptive control with feedback to individualize suramin dosing
H I Scher, D I Jodrell, J M Iversen, et al.
European Journal of Clinical Microbiology
|
October 1, 1984
The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers
G L Drusano, H C Standiford, C I Bustamante, et al.
Page
of 40
Search research articles
Search
Showing results (271-280 of 400) with videos related to
Sort By:
Page
of 40
Cancer Research
|
June 15, 1989
Phase I trial using adaptive control dosing of hexamethylene bisacetamide (NSC 95580)
B A Conley, A Forrest, M J Egorin, et al.
Journal of Clinical Pharmacology
|
August 1, 1995
Effect of aging on atenolol pharmacokinetics and pharmacodynamics
K M Sowinski, A Forrest, J H Wilton, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1995
Population pharmacokinetics and renal function-sparing effects of amphotericin B colloidal dispersion in patients receiving bone marrow transplants
M A Amantea, R A Bowden, A Forrest, et al.
Human Reproduction Update
|
February 24, 2001
Efficacy of nafarelin in assisted reproductive technology: a meta-analysis
J M Wong, K A Forrest, S Z Snabes, et al.
Cancer Research
|
June 1, 1989
A limited sampling strategy for cyclophosphamide pharmacokinetics
M J Egorin, A Forrest, C P Belani, et al.
Journal of Hepatology
|
March 26, 1998
Randomised controlled double-blind trial of the calcium channel antagonist amlodipine in the treatment of acute alcoholic hepatitis
G L Bird, A T Prach, A D McMahon, et al.
Antimicrobial Agents and Chemotherapy
|
September 1, 1987
Steady-state pharmacokinetics of imipenem in febrile neutropenic cancer patients
G L Drusano, K I Plaisance, A Forrest, et al.
Scottish Medical Journal
|
January 1, 1976
Effect of histamine H2-receptor blockade on gastric emptying and serum gastrin in man
J A Forrest, R C Heading, J Park, et al.
Cancer Research
|
January 1, 1992
Use of adaptive control with feedback to individualize suramin dosing
H I Scher, D I Jodrell, J M Iversen, et al.
European Journal of Clinical Microbiology
|
October 1, 1984
The plasma pharmacokinetics of high dose (1 g) imipenem coadministered with 1 g cilastatin in six normal volunteers
G L Drusano, H C Standiford, C I Bustamante, et al.
Page
of 40